Literature DB >> 21084394

Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer.

Pavel O Rumyantsev1, Vladimir A Saenko, Alexey A Ilyin, Valery F Stepanenko, Ulyana V Rumyantseva, Aleksandr Yu Abrosimov, Evgeny F Lushnikov, Tatiana I Rogounovitch, Yoshisada Shibata, Norisato Mitsutake, Anatoly F Tsyb, Shunichi Yamashita.   

Abstract

CONTEXT: Papillary thyroid carcinoma (PTC) in patients exposed to environmental radioiodine after the Chernobyl accident is thought to have a relatively aggressive clinical course. Long-term results of treatment are not well known, especially in comparison with sporadic PTC.
OBJECTIVE: The determination of risk factors for PTC recurrence in a controlled for baseline factors group of patients with radiation-related and sporadic PTC.
DESIGN: Retrospective cohort study involving patients treated for PTC and followed-up in 1991-2008. Risk factors were assessed by stratified analysis using the proportional hazard model.
SETTING: Referral center-based. PATIENTS: A total of 497 patients were enrolled. Patients exposed to radioiodine were 172 individuals with reconstructed individual radiation thyroid doses ranging 51-3170 mGy. Patients with sporadic PTC included 325 individuals matched to exposed patients for sex, age ± 5 yr and time to treatment ± 2 yr. MAIN OUTCOME MEASURE: Cancer recurrence.
RESULTS: Nodal disease increased the recurrence rate (HR = 5.21; 95% CI = 1.63-16.7) while the presence of tumor capsule (HR = 0.17; 95% CI = 0.06-0.45) and, particularly, treatment according to the Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer significantly reduced it (HR = 0.16; 95% CI = 0.06-0.42). None of the tested variables interacted with radiation factor.
CONCLUSIONS: PTC developing after internal exposure to radioiodine does not display specific risk factors for recurrence different from those in sporadic PTC. Common treatment approaches for patients with PTC should be recommended regardless of a history of radiation exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084394     DOI: 10.1210/jc.2010-1634

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.

Authors:  Michael G White; Nicole A Cipriani; Layth Abdulrasool; Sharone Kaplan; Briseis Aschebrook-Kilfoy; Peter Angelos; Edwin L Kaplan; Raymon H Grogan; Kenan Onel
Journal:  Thyroid       Date:  2016-08       Impact factor: 6.568

2.  Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.

Authors:  Manish A Shaha; Laura Y Wang; Jocelyn C Migliacci; Frank L Palmer; Iain J Nixon; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Thyroid       Date:  2017-02-16       Impact factor: 6.568

3.  Chernobyl-related thyroid cancer.

Authors:  Sergei V Jargin
Journal:  Eur J Epidemiol       Date:  2018-04-07       Impact factor: 8.082

4.  Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors.

Authors:  Sun Wook Cho; Hoon Sung Choi; Gye Jeong Yeom; Jung Ah Lim; Jae Hoon Moon; Do Joon Park; June-Key Chung; Bo Youn Cho; Ka Hee Yi; Young Joo Park
Journal:  Thyroid       Date:  2013-09-11       Impact factor: 6.568

5.  Clinical experiences with radiation induced thyroid cancer after chernobyl.

Authors:  Christoph Reiners
Journal:  Genes (Basel)       Date:  2011-05-31       Impact factor: 4.096

6.  Meeting report: the 5th International expert symposium in Fukushima on radiation and health.

Authors:  Vladimir A Saenko; Geraldine A Thomas; Shunichi Yamashita
Journal:  Environ Health       Date:  2017-01-18       Impact factor: 5.984

7.  Clinical significance of miR-34a expression in thyroid diseases - an 18F-FDG PET-CT study.

Authors:  Long Chen; Conghui Yang; Jun Feng; Xin Liu; Yadong Tian; Lei Zhao; Ran Xie; Chao Liu; Sheng Zhao; Hua Sun
Journal:  Cancer Manag Res       Date:  2017-12-15       Impact factor: 3.989

8.  Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.

Authors:  Shunichi Yamashita; Shinichi Suzuki; Satoru Suzuki; Hiroki Shimura; Vladimir Saenko
Journal:  Thyroid       Date:  2017-12-01       Impact factor: 6.568

9.  Prognosis of thyroid nodules in individuals living in the Zhitomir region of Ukraine.

Authors:  Naomi Hayashida; Yui Sekitani; Jumpei Takahashi; Alexander A Kozlovsky; Oleksandr K Gutevych; Aleksey S Saiko; Nina V Nirova; Anjela A Petrova; Ruslan M Rafalskiy; Sergey A Chorny; Valery V Daniliuk; Masanobu Anami; Shunichi Yamashita; Noboru Takamura
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.

Authors:  Dan Cong; Mengzi He; Silin Chen; Xiaoli Liu; Xiaodong Liu; Hui Sun
Journal:  Onco Targets Ther       Date:  2015-08-26       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.